The Effects of Videogames on Depression Symptoms and Brain Dynamics
- Sponsor
- Aalto University
- Study ID
- NCT05426265
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- MEL-T01 — DEVICEA 12 week intervention with MEL-T01.
- MEL-S01 — DEVICEA 12 week intervention with MEL-S01.
Study Details
The purpose of the study is to evaluate the effects of a game-based digital-therapeutics (DTx) medical software device on the symptoms of depression in adults with confirmed major depressive disorder.
Key Dates
- Start date
- Jun 28, 2022
- Status verified
- Apr 2026
- Primary completion
- Aug 14, 2024
- Completion
- Aug 14, 2024
Study Design
- Enrollment
- 1,001 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: MEL-T01MEL-T01 is a game-based digital-therapeutics (DTx) medical software device that implements personalised cognitive training to alleviate MDD symptoms and improve cognitive performance in MDD subjects.
- Active Comparator: MEL-S01MEL-S01 is an active comparator similar to MEL-T01 but without personalized cognitive training elements.
- No Intervention: TAUTreatment-as-usual.
Primary Outcome Measure
PHQ-9 Total Change From Baseline to Posttreatment: Experimental Group vs. Treatment as Usual Group [ Time Frame: Day 0 to Day 84 ]
Related Studies
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety DisordersPHASE2 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive DisorderPHASE1 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- DBS for DepressionRecruiting · Baylor College of Medicine · Dallas, Texas
- Nitrous Oxide- Suicidal IdeationPHASE1 · Enrolling By Invitation · Washington University School of Medicine · St Louis, Missouri